Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow's milk protein allergy.

Details

Serval ID
serval:BIB_04DB74815063
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Efficacy and safety of hydrolyzed rice-protein formulas for the treatment of cow's milk protein allergy.
Journal
Archives de pediatrie
Author(s)
Bocquet A., Dupont C., Chouraqui J.P., Darmaun D., Feillet F., Frelut M.L., Girardet J.P., Hankard R., Lapillonne A., Rozé J.C., Simeoni U., Turck D., Briend A.
Working group(s)
Committee on Nutrition of the French Society of Pediatrics (CNSFP)
ISSN
1769-664X (Electronic)
ISSN-L
0929-693X
Publication state
Published
Issued date
05/2019
Peer-reviewed
Oui
Volume
26
Number
4
Pages
238-246
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Foods for special medical purposes (FSMPs) with a protein fraction made of hydrolyzed rice protein (HRPs) have been on the market in Europe since the 2000s for the treatment of cow's milk protein allergy (CMPA). HRP formulas (HRPFs) are proposed as a plant-based alternative to cow's milk protein-based extensively hydrolyzed formulas (CMP-eHF) beside the soy protein formulas whose use in CMPA is controversial. HRPFs do not contain phytoestrogens and are derived from non-genetically modified rice. HRPFs are strictly plant-based apart from the addition of vitamin D <sub>3</sub> (cholecalciferol). As the amino acid content of rice proteins differs from that of human milk proteins, the protein quality of these formulas is improved by supplementation with free lysine, threonine, and tryptophan. The consumption of HRPFs has risen: for example, in France HRPFs account for 4.9% in volume of all formulas for children aged 0-3 years. Several studies have shown the adequacy of HRPFs in treating CMPA. They ensure satisfactory growth from the 1st weeks of life for infants and toddlers, both in healthy children and in those with CMPA. HRPFs can be used to treat children with CMPA either straightaway or in second intention in cases of poor tolerance to CMP-eHF for organoleptic reasons or for lack of efficacy. In France, the cost of HRPFs is close to that of regular infant or follow-on formulas.
Keywords
Cow's milk allergy, Extensively hydrolyzed cow's milk protein formula, Growth, Hydrolyzed formulas, Hydrolyzed rice-protein formulas
Pubmed
Web of science
Create date
28/04/2019 15:04
Last modification date
20/08/2019 12:26
Usage data